These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15717054)

  • 1. How to measure drug transport across the blood-brain barrier.
    Bickel U
    NeuroRx; 2005 Jan; 2(1):15-26. PubMed ID: 15717054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo.
    Feng MR
    Curr Drug Metab; 2002 Dec; 3(6):647-57. PubMed ID: 12369891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier.
    de Lange EC; Danhof M; de Boer AG; Breimer DD
    Brain Res Brain Res Rev; 1997 Sep; 25(1):27-49. PubMed ID: 9370049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier.
    Josserand V; Pélerin H; de Bruin B; Jego B; Kuhnast B; Hinnen F; Ducongé F; Boisgard R; Beuvon F; Chassoux F; Daumas-Duport C; Ezan E; Dollé F; Mabondzo A; Tavitian B
    J Pharmacol Exp Ther; 2006 Jan; 316(1):79-86. PubMed ID: 16210395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R; Decleves X; Scherrmann JM
    Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods to assess drug permeability across the blood-brain barrier.
    Nicolazzo JA; Charman SA; Charman WN
    J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
    Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo, in vitro and in silico methods for small molecule transfer across the BBB.
    Mensch J; Oyarzabal J; Mackie C; Augustijns P
    J Pharm Sci; 2009 Dec; 98(12):4429-68. PubMed ID: 19408294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efflux transporters in the blood-brain interfaces--in vitro and in vivo methods and correlations.
    Krajcsi P; Jani M; Tóth B; Erdo F; Kis E; Beéry E; Sziráki I
    Expert Opin Drug Metab Toxicol; 2012 Apr; 8(4):419-31. PubMed ID: 22394316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies.
    Cucullo L; Couraud PO; Weksler B; Romero IA; Hossain M; Rapp E; Janigro D
    J Cereb Blood Flow Metab; 2008 Feb; 28(2):312-28. PubMed ID: 17609686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New approaches to in vitro models of blood-brain barrier drug transport.
    Terasaki T; Ohtsuki S; Hori S; Takanaga H; Nakashima E; Hosoya K
    Drug Discov Today; 2003 Oct; 8(20):944-54. PubMed ID: 14554158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
    Lossinsky AS; Shivers RR
    Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRna expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting.
    Hosoya KI; Takashima T; Tetsuka K; Nagura T; Ohtsuki S; Takanaga H; Ueda M; Yanai N; Obinata M; Terasaki T
    J Drug Target; 2000; 8(6):357-70. PubMed ID: 11328662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.
    de Lange EC; Danhof M
    Clin Pharmacokinet; 2002; 41(10):691-703. PubMed ID: 12162757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic consequences of active drug efflux at the blood-brain barrier.
    Syvänen S; Xie R; Sahin S; Hammarlund-Udenaes M
    Pharm Res; 2006 Apr; 23(4):705-17. PubMed ID: 16575498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of drug transporters at the blood-brain barrier.
    Fricker G; Miller DS
    Pharmacology; 2004 Apr; 70(4):169-76. PubMed ID: 15001817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier: an impediment to neuropharmaceuticals.
    Henderson JT; Piquette-Miller M
    Clin Pharmacol Ther; 2015 Apr; 97(4):308-13. PubMed ID: 25670372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
    Pardridge WM
    Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of choline transport across the blood-brain barrier in mice: correlation with in vitro data.
    Murakami H; Sawada N; Koyabu N; Ohtani H; Sawada Y
    Pharm Res; 2000 Dec; 17(12):1526-30. PubMed ID: 11303963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug transport across the blood-brain barrier.
    Pardridge WM
    J Cereb Blood Flow Metab; 2012 Nov; 32(11):1959-72. PubMed ID: 22929442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.